GSK plc (GSK) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - General industry. The company is headquartered in Brentford, United Kingdom. The current CEO is Luke Victor Miels.
GSK has IPO date of 1980-03-28, 68,629 full-time employees, listed on the NYSE, a market capitalization of $118.67B.
GSK plc is a global pharmaceutical and vaccine company headquartered in Brentford, United Kingdom, engaged in the research, development, and manufacture of vaccines and specialty medicines. The company's portfolio includes vaccines for shingles, meningitis, respiratory syncytial virus, influenza, and polio, as well as medicines for HIV, oncology, respiratory and immunology conditions, and antibiotics. GSK operates through Commercial Operations and Total R&D segments, serving markets across the United Kingdom, United States, and internationally. The company has established multiple strategic collaborations, including partnerships with CureVac for mRNA-based influenza vaccines, Wave Life Sciences for oligonucleotide platform development, and Flagship Pioneering for novel medicines and vaccines discovery. Founded in 1715 and rebranded as GSK plc in 2022, the company remains a leading player in global healthcare innovation.
